Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Agric Food Chem ; 68(39): 10709-10718, 2020 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-32880448

RESUMO

Nobiletin, one of the prevalent polymethoxyflavones in citrus peels, was reported to possess various health benefits. We conducted the excretion study and pharmacokinetics study of nobiletin via oral administration and intravenous injection and 15 day consecutive dosing study using the high fat diet-induced obese rats and their lean counterparts. By comparing the demethylated metabolite profiles in the urine and feces, gut microbiota demonstrated greater biotransformation activity on nobiletin than the host. The absolute oral bioavailability of nobiletin in lean (22.37% ± 4.52%) and obese (18.67% ± 4.80%) rats has a negligible statistically significant difference (P > 0.05). However, a higher extent of demethylated metabolites was found in the feces and plasma of obese rats than lean rats (P < 0.05). Moreover, the consecutive dosing of nobiletin might lead to a higher extent of demethylated metabolites in the plasma and in feces. These results suggested that gut microbiota played important roles in nobiletin metabolism.


Assuntos
Flavonas/metabolismo , Obesidade/tratamento farmacológico , Extratos Vegetais/metabolismo , Animais , Disponibilidade Biológica , Biotransformação , Citrus/química , Fezes/química , Flavonas/administração & dosagem , Flavonas/sangue , Flavonas/urina , Microbioma Gastrointestinal , Humanos , Masculino , Obesidade/sangue , Obesidade/microbiologia , Obesidade/urina , Extratos Vegetais/administração & dosagem , Extratos Vegetais/sangue , Extratos Vegetais/urina , Ratos , Ratos Sprague-Dawley
2.
Clin Nutr ; 39(1): 291-297, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-30792141

RESUMO

The aim of this study was to investigate the effect of the ingestion of tomato before bed on obese postmenopausal women's urinary 6-sulphatoxymelatonin (aMT6s) level and sleep quality. We quantified melatonin concentrations in beefsteak tomato, black tomato, and two commercial tomato juices and found that beefsteak tomato contained the highest level of melatonin. In this 8-week open-label, randomized controlled dietary intervention trial, 36 subjects completed the entire trial. The tomato group ate 250 g of beefsteak tomatoes 2 h before sleep for 8 weeks. Blood and urine samples were collected at the baseline and in the 8th week and were analyzed. The Pittsburgh Sleep Quality Index (PSQI) in the tomato group significantly decreased with time (p for trend = 0.0297). After 8 weeks of the beefsteak intervention, all components of the PSQI in tomato group had significantly improved, and their aMT6s level was 10-fold significantly higher than that of the control group. Therefore, supplementation with beefsteak tomato before sleep can increase circulating melatonin and improve sleep quality in obese postmenopausal women.


Assuntos
Dieta/métodos , Melatonina/análogos & derivados , Obesidade/urina , Pós-Menopausa/urina , Sono , Solanum lycopersicum/metabolismo , Feminino , Humanos , Masculino , Melatonina/urina , Pessoa de Meia-Idade
3.
J Agric Food Chem ; 67(40): 11099-11107, 2019 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-31496244

RESUMO

Urolithins are bioactive gut microbiota metabolites of ellagic acid. Here, we have identified four unknown urolithins in human feces after the intake of a pomegranate extract. The new metabolites occurred only in 19% of the subjects. 4,8,9,10-Tetrahydroxy urolithin, (urolithin M6R), was unambiguously identified by 1H NMR, UV, and HRMS. Three metabolites were tentatively identified by the UV, HRMS, and chromatographic behavior, as 4,8,10-trihydroxy (urolithin M7R), 4,8,9-trihydroxy (urolithin CR), and 4,8-dihydroxy (urolithin AR) urolithins. Phase II conjugates of the novel urolithins were detected in urine and confirmed their absorption, circulation, and urinary excretion. The production of the new urolithins was not specific of any of the known urolithin metabotypes A and B. The new metabolites needed a bacterial 3-dehydroxylase activity for their production, and this is a novel feature as all the previously known urolithins maintained the hydroxyl at 3 position. The ability of production of these "R" urolithins can be considered an additional metabolic feature for volunteer stratification.


Assuntos
Cumarínicos/metabolismo , Fezes/química , Lythraceae/metabolismo , Obesidade/dietoterapia , Extratos Vegetais/metabolismo , Urina/química , Adulto , Idoso , Cumarínicos/química , Ácido Elágico/química , Ácido Elágico/metabolismo , Feminino , Humanos , Lythraceae/química , Masculino , Pessoa de Meia-Idade , Obesidade/metabolismo , Obesidade/urina , Extratos Vegetais/química
4.
Nutr Diabetes ; 9(1): 19, 2019 06 05.
Artigo em Inglês | MEDLINE | ID: mdl-31168050

RESUMO

BACKGROUND: The role of resistant starch (RS) in glucose, insulin, insulin resistance or sensitivity, and lipid parameters have been reported in several studies and remained controversial. A pooled analysis which assessed these parameters has not been performed. Thus, we conducted a meta-analysis to sum up existing evidence about the issue. METHODS: We searched in MEDLINE and PUBMED for studies that were published before November 2018. Meta-analysis of diabetics and nondiabetics trials were performed by use of a random-effects model. RESULTS: A total of 13 case-control studies that included 428 subjects with body mass index ≥25 were identified. RS supplementation reduced fasting insulin in overall and stratified (diabetics and nondiabetics trials) analysis (SMD = -0.72; 95% CI: -1.13 to -0.31; SMD = -1.26; 95% CI: -1.66 to -0.86 and SMD = -0.64; 95% CI: -1.10 to -0.18, respectively), and reduced fasting glucose in overall and stratified analysis for diabetic trials (SMD = -0.26; 95% CI: -0.5 to -0.02 and SMD = -0.28; 95% CI: -0.54 to -0.01, respectively). RS supplementation increased HOMA-S% (SMD = 1.19; 95% CI: 0.59-1.78) and reduced HOMA-B (SMD =-1.2; 95% CI: -1.64 to -0.77), LDL-c concentration (SMD =-0.35; 95% CI: -0.61 to -0.09), and HbA1c (SMD = -0.43; 95% CI: -0.74 to -0.13) in overall analysis. CONCLUSIONS: This meta-analysis has provided evidence that RS supplementation can improve fasting glucose, fasting insulin, insulin resistance and sensitivity, especially for diabetic with overweight or obesity. However, owing to potential sophistication, individual difference and composition of intestinal microbiota, this result should be carefully taken into account.


Assuntos
Suplementos Nutricionais , Resistência à Insulina/fisiologia , Insulina/sangue , Lipídeos/sangue , Obesidade/sangue , Sobrepeso/sangue , Amido , Glicemia , Humanos , Obesidade/urina , Sobrepeso/terapia , Resultado do Tratamento
5.
Appl Biochem Biotechnol ; 189(2): 690-708, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31111377

RESUMO

The present studies are to evaluate the ability of PB to induce weight loss and urine metabolite profile of Piper betle L. (PB) leaf extracts using metabolomics approach. Dried PB leaves were extracted with ethanol 70% and the studies were performed in different groups of rats fed with high fat (HFD) and normal diet (ND). Then, fed with the PB extract with 100, 300, and 500 mg/kg and two negative control groups given water (WTR). The body weights were monitored and evaluated. Urine was collected and 1H NMR-based metabolomics approach was used to detect the metabolite changes. Results showed that PB-treated group demonstrated inhibition of body weight gain. The trajectory of urine metabolites showed that PB-treated group gave the different distribution from week 12 to 16 compared with the control groups. In 1H NMR metabolomic approach analysis, the urine metabolites gave the best separation in principle component 1 and 3, with 40.0% and 9.56% of the total variation. Shared and unique structures (SUS) plot model showed that higher concentration PB-treated group was characterized by high level of indole-3-acetate, aspartate, methanol, histidine, and creatine, thus caused an increased the metabolic function and maintaining the body weight of the animals treated.


Assuntos
Metabolômica , Ressonância Magnética Nuclear Biomolecular , Obesidade , Piper betle/química , Extratos Vegetais , Folhas de Planta/química , Animais , Gorduras na Dieta/efeitos adversos , Gorduras na Dieta/farmacologia , Masculino , Metaboloma/efeitos dos fármacos , Obesidade/induzido quimicamente , Obesidade/tratamento farmacológico , Obesidade/urina , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Ratos , Ratos Sprague-Dawley
6.
Reprod Sci ; 26(8): 1025-1033, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30773100

RESUMO

Dietary fish oil restores ovarian function in subfertile rats, which is thought to be associated with decreased transcription of follicle-stimulating hormone (FSH) ß-subunit. We have previously demonstrated a reduction in early follicular serum FSH levels in normal weight but not obese women after treatment with omega-3 polyunsaturated fatty acids (PUFA). Herein, we report the effect of supplementation with omega-3 PUFA on urinary reproductive hormones across the whole menstrual cycle. This interventional study included 17 eumenorrheic women, aged 24-41 years. One month of daily morning urine was collected before and after 1 month of omega-3 PUFA supplementation with 4 g of eicosapentaenoic acid and docosahexaenoic acid daily. Measurements included urinary FSH, luteinizing hormone (LH) and estrogen and progesterone metabolites, plasma fatty acid composition, and markers of endoplasmic reticulum stress. Compliance with dietary supplementation was verified by significantly reduced ratios of omega-6 to omega-3 PUFA for all subjects after treatment (P < .01). After 1 month of omega-3 PUFA supplementation, urinary FSH was significantly decreased in normal weight, but not obese women, in both follicular and luteal phases (-28.4% and -12.6%, respectively, both P = .04). No significant changes were seen in LH or sex steroids for either weight group. The selective and specific decrease in FSH suggests that omega-3 PUFA supplementation merits further investigation in normal weight women with decreased fertility and/or diminished ovarian reserve.


Assuntos
Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácido Eicosapentaenoico/administração & dosagem , Hormônio Foliculoestimulante/urina , Ciclo Menstrual/urina , Obesidade/urina , Adulto , Suplementos Nutricionais , Estrogênios/urina , Feminino , Humanos , Hormônio Luteinizante/urina , Ciclo Menstrual/efeitos dos fármacos , Progestinas/urina , Adulto Jovem
7.
Toxicol Pathol ; 46(7): 777-798, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-30343647

RESUMO

The obese rodent serves as an indispensable tool for proof-of-concept efficacy and mode-of-action pharmacology studies. Yet the utility of this disease model as an adjunct to the conventional healthy animal in the nonclinical safety evaluation of anti-obesity pharmacotherapies has not been elucidated. Regulatory authorities have recommended employing disease models in toxicology studies when necessary. Our study investigated standard and exploratory toxicology parameters in the high-fat diet (HFD)-induced obese, polygenic Sprague-Dawley rat model in comparison to chow diet (CD)-fed controls. We sought to establish feasibility of the model for safety testing and relevance to human obesity pathophysiology. We report that both sexes fed a 45% kcal HFD for 29 weeks developed obesity and metabolic derangements that mimics to a certain extent, common human obesity. Minor clinical pathologies were observed in both sexes and considered related to CD versus HFD differences. Histopathologically, both sexes exhibited mild obesity-associated findings in brown and subcutaneous white fat, bone, kidneys, liver, lung, pancreas, salivary parotid glands, and skeletal muscle. We conclude that chronic HFD feeding in both sexes led to the development of an obese but otherwise healthy rat. Therefore, the diet-induced obese Sprague-Dawley rat may serve as a suitable model for evaluating toxicity findings encountered with anti-obesity compounds.


Assuntos
Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Obesidade/etiologia , Animais , Fármacos Antiobesidade/toxicidade , Biomarcadores/sangue , Biomarcadores/urina , Peso Corporal/fisiologia , Avaliação Pré-Clínica de Medicamentos , Ciclo Estral/fisiologia , Feminino , Masculino , Obesidade/sangue , Obesidade/fisiopatologia , Obesidade/urina , Tamanho do Órgão/fisiologia , Especificidade de Órgãos/fisiologia , Estudo de Prova de Conceito , Ratos Sprague-Dawley
8.
Biol Pharm Bull ; 41(10): 1581-1585, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30270327

RESUMO

The objective of this study was to confirm the effect of maternal genistein exposure on body weight of male offspring and the metabolic alterations associated with maternal genistein-induced obesity. Pregnant female Sprague-Dawley (SD) rats were supplemented with 300 mg/kg diet of genistein (GEN) or no genistein (CON) throughout pregnancy and lactation. The growth of male offspring was investigated until 12 week age and the mechanism of obesity was studied using metabonomics by ultra performance liquid chromatography and quadrupole time-of-flight (UPLC Q-TOF) MS with electrospray ionization in positive ESI mode (ESI+). Compared with the CON group, body weight, fat pad and food intake of male offspring in GEN group were increased significantly at the age of weeks 10 to 12 (p<0.05). Ten urine principal metabolites contributing to the clusters were identified, including increased 8-Isoprostaglandin F2a, and decreased L-Proline, Betaine, L-Acetylcarnitine, Norsalsolinol, Indoleacrylic acid, L-Tryptophan, Lysophosphatidylcholines (LysoPC) (20 : 4), Lysophosphatidylethanolamines (LysoPE) (18 : 1) and LysoPC (O-18 : 0). Our results confirmed weight-increasing effects of maternal genistein exposure, accompanied by favorable changes in metabolites in the male offspring' urine. Therefore, this research enables us to better understand obesity and predict risk of obesity-related disease by studying metabolites present in the urine.


Assuntos
Genisteína/efeitos adversos , Lactação , Fenômenos Fisiológicos da Nutrição Materna , Metaboloma , Obesidade/etiologia , Fitoestrógenos/efeitos adversos , Efeitos Tardios da Exposição Pré-Natal , Tecido Adiposo/metabolismo , Animais , Biomarcadores/metabolismo , Cromatografia Líquida de Alta Pressão , Dieta , Suplementos Nutricionais , Ingestão de Alimentos , Feminino , Masculino , Metabolômica/métodos , Obesidade/urina , Gravidez , Ratos Sprague-Dawley , Espectrometria de Massas por Ionização por Electrospray , Aumento de Peso
9.
JCI Insight ; 3(16)2018 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-30135311

RESUMO

Although the cause of hypertension among individuals with obesity and insulin resistance is unknown, increased plasma insulin, acting in the kidney to increase sodium reabsorption, has been proposed as a potential mechanism. Insulin may also stimulate glucose uptake, but the contributions of tubular insulin signaling to sodium or glucose transport in the setting of insulin resistance is unknown. To directly study the role of insulin signaling in the kidney, we generated inducible renal tubule-specific insulin receptor-KO mice and used high-fat feeding and mineralocorticoids to model obesity and insulin resistance. Insulin receptor deletion did not alter blood pressure or sodium excretion in mice on a high-fat diet alone, but it mildly attenuated the increase in blood pressure with mineralocorticoid supplementation. Under these conditions, KO mice developed profound glucosuria. Insulin receptor deletion significantly reduced SGLT2 expression and increased urinary glucose excretion and urine flow. These data demonstrate a direct role for insulin receptor-stimulated sodium and glucose transport and a functional interaction of insulin signaling with mineralocorticoids in vivo. These studies uncover a potential mechanistic link between preserved insulin sensitivity and renal glucose handling in obesity and insulin resistance.


Assuntos
Glucose/metabolismo , Resistência à Insulina/fisiologia , Insulina/metabolismo , Túbulos Renais/metabolismo , Obesidade/metabolismo , Receptor de Insulina/metabolismo , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Fludrocortisona/administração & dosagem , Fludrocortisona/efeitos adversos , Glicosúria/etiologia , Glicosúria/metabolismo , Humanos , Hipertensão/induzido quimicamente , Hipertensão/diagnóstico , Hipertensão/metabolismo , Túbulos Renais/efeitos dos fármacos , Masculino , Camundongos , Camundongos Knockout , Obesidade/etiologia , Obesidade/urina , Receptor de Insulina/genética , Eliminação Renal/efeitos dos fármacos , Reabsorção Renal/efeitos dos fármacos , Sódio na Dieta/administração & dosagem , Sódio na Dieta/efeitos adversos , Sódio na Dieta/metabolismo
10.
J Physiol Biochem ; 74(3): 403-416, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29766441

RESUMO

Diabetes mellitus (DM) is a chronic disease that can affect metabolism of glucose and other metabolites. In this study, the normal- and obese-diabetic rats were compared to understand the diabetes disorders of type 1 and 2 diabetes mellitus. This was done by evaluating their urine metabolites using proton nuclear magnetic resonance (1H NMR)-based metabolomics and comparing with controls at different time points, considering the induction periods of obesity and diabetes. The biochemical parameters of the serum were also investigated. The obese-diabetic model was developed by feeding the rats a high-fat diet and inducing diabetic conditions with a low dose of streptozotocin (STZ) (25 mg/kg bw). However, the normal rats were induced by a high dose of STZ (55 mg/kg bw). A partial least squares discriminant analysis (PLS-DA) model showed the biomarkers of both DM types compared to control. The synthesis and degradation of ketone bodies, tricarboxylic (TCA) cycles, and amino acid pathways were the ones most involved in the variation with the highest impact. The diabetic groups also exhibited a noticeable increase in the plasma glucose level and lipid profile disorders compared to the control. There was also an increase in the plasma cholesterol and low-density lipoprotein (LDL) levels and a decline in the high-density lipoprotein (HDL) of diabetic rats. The normal-diabetic rats exhibited the highest effect of all parameters compared to the obese-diabetic rats in the advancement of the DM period. This finding can build a platform to understand the metabolic and biochemical complications of both types of DM and can generate ideas for finding targeted drugs.


Assuntos
Diabetes Mellitus Experimental/sangue , Hipoglicemiantes/farmacologia , Metaboloma , Metformina/farmacologia , Obesidade/sangue , Aminoácidos/sangue , Aminoácidos/urina , Animais , Glicemia/metabolismo , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Experimental/urina , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/etiologia , Diabetes Mellitus Tipo 1/patologia , Diabetes Mellitus Tipo 1/urina , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/etiologia , Diabetes Mellitus Tipo 2/patologia , Diabetes Mellitus Tipo 2/urina , Dieta Hiperlipídica/efeitos adversos , Corpos Cetônicos/sangue , Corpos Cetônicos/urina , Masculino , Metabolômica/métodos , Obesidade/etiologia , Obesidade/patologia , Obesidade/urina , Análise de Componente Principal , Ratos , Ratos Sprague-Dawley , Estreptozocina
11.
Nutrients ; 9(10)2017 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-28961176

RESUMO

There has been substantial interest in phytoestrogens, because of their potential effect in reducing cancer and heart disease risk. Measuring concentrations of phytoestrogens in urine is an alternative method for conducting epidemiological studies. Our objective was to evaluate the urinary excretion of phytoestrogens as biomarkers for dietary phytoestrogen intake in Mexican women. Participants were 100 healthy women from 25 to 80 years of age. A food frequency questionnaire (FFQ) and a 24 h recall were used to estimate habitual and recent intakes of isoflavones, lignans, flavonols, coumestrol, resveratrol, naringenin, and luteolin. Urinary concentrations were measured by liquid chromatography (HPLC) coupled to mass spectrometry (MS) using the electrospray ionization interface (ESI) and diode array detector (DAD) (HPLC-DAD-ESI-MS). Spearman correlation coefficients were used to evaluate associations between dietary intake and urine concentrations. The habitual consumption (FFQ) of total phytoestrogens was 37.56 mg/day. In urine, the higher compounds were naringenin (60.1 µg/L) and enterolactone (41.7 µg/L). Recent intakes (24 h recall) of isoflavones (r = 0.460, p < 0.001), lignans (r = 0.550, p < 0.0001), flavonoids (r = 0.240, p < 0.05), and total phytoestrogens (r = 0.410, p < 0.001) were correlated to their urinary levels. Total phytoestrogen intakes estimated by the FFQ showed higher correlations to urinary levels (r = 0.730, p < 0.0001). Urinary phytoestrogens may be useful as biomarkers of phytoestrogen intake, and as a tool for evaluating the relationship of intake and disease risk in Mexican women.


Assuntos
Dieta Saudável , Cardiopatias/prevenção & controle , Neoplasias/prevenção & controle , Cooperação do Paciente , Fitoestrógenos/administração & dosagem , Fitoestrógenos/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/urina , Índice de Massa Corporal , Estudos Transversais , Dieta Saudável/etnologia , Feminino , Cardiopatias/epidemiologia , Cardiopatias/etnologia , Cardiopatias/urina , Humanos , México/epidemiologia , Pessoa de Meia-Idade , Neoplasias/epidemiologia , Neoplasias/etnologia , Neoplasias/urina , Inquéritos Nutricionais , Obesidade/epidemiologia , Obesidade/etnologia , Obesidade/prevenção & controle , Obesidade/urina , Sobrepeso/epidemiologia , Sobrepeso/etnologia , Sobrepeso/prevenção & controle , Sobrepeso/urina , Cooperação do Paciente/etnologia , Prevalência , Risco
12.
J Proteome Res ; 16(8): 2924-2935, 2017 08 04.
Artigo em Inglês | MEDLINE | ID: mdl-28631923

RESUMO

This study evaluated the effect of ingesting a flavonoid-rich supplement (329 mg/d) on total urine phenolics and shifts in plasma metabolites in overweight/obese female adults using untargeted metabolomics procedures. Participants (N = 103, 18-65 y, BMI ≥ 25 kg/m2) were randomized to flavonoid (F) or placebo (P) groups for 12 weeks with blood and 24 h urine samples collected prestudy and after 4 and 12 weeks in a parallel design. Supplements were prepared as chewable tablets and included vitamin C, wild bilberry fruit extract, green tea leaf extract, quercetin, caffeine, and omega 3 fatty acids. At 4 weeks, urine total phenolics increased 24% in F versus P with similar changes at 12 weeks (interaction effect, P = 0.041). Groups did not differ in markers of inflammation (IL-6, MCP-1, CRP) or oxidative stress (oxLDL, FRAP). Metabolomics data indicated shifts in 63 biochemicals in F versus P with 70% from the lipid and xenobiotics superpathways. The largest fold changes in F were measured for three gut-derived phenolics including 3-methoxycatechol sulfate, 3-(3-hydroxyphenyl)propanoic acid sulfate, and 1,2,3-benzenetriol sulfate (interaction effects, p ≤ 0.050). This randomized clinical trial of overweight/obese women showed that 12 weeks ingestion of a mixed flavonoid nutrient supplement was associated with a corresponding increase in urine total phenolics and gut-derived phenolic metabolites.


Assuntos
Flavonoides/farmacologia , Metaboloma/efeitos dos fármacos , Sobrepeso/metabolismo , Fenóis/urina , Adolescente , Adulto , Idoso , Suplementos Nutricionais , Feminino , Flavonoides/administração & dosagem , Humanos , Mucosa Intestinal/metabolismo , Metabolômica/métodos , Pessoa de Meia-Idade , Obesidade/metabolismo , Obesidade/urina , Sobrepeso/urina , Adulto Jovem
13.
J Nutr Biochem ; 33: 111-8, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27155917

RESUMO

Studies on metabolism of polyphenols have revealed extensive transformations in the carbon backbone by colonic microbiota; however, the influence of microbial and hepatic transformations on human urinary metabolites has not been explored. Therefore, the aims of this study were (1) to compare the in vitro microbial phenolic metabolite profile of foods and beverages with that excreted in urine of subjects consuming the same foodstuff and (2) to explore the role of liver on postcolonic metabolism of polyphenols by using in vitro hepatic models. A 24-h urinary phenolic metabolite profile was evaluated in 72 subjects participating in an 8-week clinical trial during which they were randomly assigned to diets differing for polyphenol content. Polyphenol-rich foods and beverages used in the clinical trial were subjected to human fecal microbiota in the in vitro colon model. Metabolites from green tea, one of the main components of the polyphenol-rich diet, were incubated with primary hepatocytes to highlight hepatic conversion of polyphenols. The analyses were performed using targeted gas chromatography with mass spectrometer (GCxGC-TOFMS:colon model; GC-MS: urine and hepatocytes). A significant correlation was found between urinary and colonic metabolites with C1-C3 side chain (P=.040). However, considerably higher amounts of hippuric acid, 3-hydroxybenzoic acid and ferulic acid were detected in urine than in the colon model. The hepatic conversion showed additional amounts of these metabolites complementing the gap between in vitro colon model and the in vivo urinary excretion. Therefore, combining in vitro colon and hepatic models may better elucidate the metabolism of polyphenols from dietary exposure to urinary metabolites.


Assuntos
Colo/microbiologia , Dieta , Microbioma Gastrointestinal , Fígado/metabolismo , Modelos Biológicos , Sobrepeso/metabolismo , Polifenóis/metabolismo , Adulto , Algoritmos , Células Cultivadas , Ácidos Cumáricos/metabolismo , Ácidos Cumáricos/urina , Fezes/microbiologia , Manipulação de Alimentos , Hipuratos/metabolismo , Hipuratos/urina , Humanos , Hidroxibenzoatos/metabolismo , Hidroxibenzoatos/urina , Mucosa Intestinal/microbiologia , Fígado/citologia , Obesidade/metabolismo , Obesidade/urina , Sobrepeso/urina , Oxirredução , Polifenóis/administração & dosagem , Polifenóis/urina , Chá/química
14.
Food Funct ; 7(4): 1924-31, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26961599

RESUMO

Metabolomics is used to assess the compliance and bioavailability of food components, as well as to evaluate the metabolic changes associated with food consumption. This study aimed to analyze the effect of consuming ready-to-eat meals containing a cocoa extract, within an energy restricted diet on urinary metabolomic changes. Fifty middle-aged volunteers [30.6 (2.3) kg m(-2)] participated in a 4-week randomised, parallel and double-blind study. Half consumed meals supplemented with 1.4 g of cocoa extract (645 mg polyphenols) while the remaining subjects received meals without cocoa supplementation. Ready-to-eat meals were included within a 15% energy restricted diet. Urine samples (24 h) were collected at baseline and after 4 weeks and were analyzed by high-performance-liquid chromatography-time-of-flight-mass-spectrometry (HPLC-TOF-MS) in negative and positive ionization modes followed by multivariate analysis. The relationship between urinary metabolites was evaluated by the Spearman correlation test. Interestingly, the principal component analysis discriminated among the baseline group, control group at the endpoint and cocoa group at the endpoint (p < 0.01), although in the positive ionization mode the baseline and control groups were not well distinguished. Metabolites were related to theobromine metabolism (3-methylxanthine and 3-methyluric acid), food processing (L-beta-aspartyl-L-phenylalanine), flavonoids (2,5,7,3',4'-pentahydroxyflavanone-5-O-glucoside and 7,4'-dimethoxy-6-C-methylflavanone), catecholamine (3-methoxy-4-hydroxyphenylglycol-sulphate) and endogenous metabolism (uridine monophosphate). These metabolites were present in higher (p < 0.001) amounts in the cocoa group. 3-Methylxanthine and l-beta-aspartyl-L-phenylalanine were confirmed with standards. Interestingly, 3-methoxy-4-hydroxyphenylglycol-sulphate was positively correlated with 3-methylxanthine (rho = 0.552; p < 0.001) and 7,4'-dimethoxy-6-C-methylflavanone (rho = 447; p = 0.002). In conclusion, the metabolomic approach supported the compliance of the volunteers with the intervention and suggested the bioavailability of cocoa compounds within the meals.


Assuntos
Cacau/metabolismo , Obesidade/dietoterapia , Obesidade/urina , Extratos Vegetais/metabolismo , Idoso , Idoso de 80 Anos ou mais , Cacau/química , Cromatografia Líquida de Alta Pressão , Suplementos Nutricionais/análise , Método Duplo-Cego , Feminino , Humanos , Masculino , Espectrometria de Massas , Metabolômica , Pessoa de Meia-Idade , Obesidade/metabolismo , Extratos Vegetais/análise
15.
J Ethnopharmacol ; 180: 60-9, 2016 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-26775274

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: 'Pegaga' is a traditional Malay remedy for a wide range of complaints. Among the 'pegaga', Centella asiatica has been used as a remedy for diabetes mellitus. Thus, we decided to validate this claim by evaluating the in vivo antidiabetic property of C. asiatica (CA) on T2DM rat model using the holistic (1)H NMR-based metabolomics approach. METHOD: In this study, an obese diabetic (mimic of T2DM condition) animal model was developed using Sprague-Dawley rats fed with a high-fat diet and induced into diabetic condition by the treatment of a low dose of streptozotocin (STZ). The effect of C. asiatica extract on the experimental animals was followed based on the changes observed in the urinary and serum metabolites, measured by (1)H NMR of urine and blood samples collected over the test period. RESULTS: A long-term treatment of obese diabetic rats with CA extract could reverse the glucose and lipid levels, as well as the tricarboxylic acid cycle and amino acid metabolic disorders, back towards normal states. Biochemical analysis also showed an increase of insulin production in diabetic rats upon treatment of CA extract. CONCLUSION: This study has provided evidence that clearly supported the traditional use of CA as a remedy for diabetes. NMR-based metabolomics was successfully applied to show that CA produced both anti-hyperglycemic and anti-hyperlipidemic effects on a rat model. In addition to increasing the insulin secretion, the CA extract also ameliorates the metabolic pathways affected in the induced diabetic rats. This study further revealed the potential usage of CA extract in managing diabetes mellitus and the results of this work may contribute towards the further understanding of the underlying molecular mechanism of this herbal remedy.


Assuntos
Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/urina , Obesidade/sangue , Obesidade/urina , Triterpenos/farmacologia , Animais , Centella , Dieta Hiperlipídica , Espectroscopia de Ressonância Magnética , Masculino , Metabolômica , Extratos Vegetais , Ratos Sprague-Dawley
16.
Amino Acids ; 47(9): 1697-702, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26210755

RESUMO

The year 2008 witnessed the first report on the increase in the concentration of L-homoarginine (hArg) in the maternal plasma during human pregnancy. This observation, along with a well-known function of hArg, the methylene homologue of L-arginine (Arg), as a substrate for nitric oxide (NO) synthase, was the ignition for the start of intense research on the physiology and pathology of hArg. The circulating concentration of hArg was found to be lower in patients suffering from various diseases, and hArg emerged within only very few years as a novel cardiovascular risk factor. The compendium in hand comprises original and review articles covering several aspects of hArg, Arg and its symmetrically and asymmetrically guanidine (N (G))-dimethylated derivatives SDMA and ADMA, respectively. In contrast to ADMA and SDMA, low hArg concentrations in plasma or serum and in urine are associated with high risks for morbidity and mortality, notably in the renal and cardiovascular systems. Acutely and chronically administered Arg as a nutritional supplement or in the form of dietary proteins is safe in animals and humans and leads to concomitant formation of hArg and ADMA, albeit in a different hArg/ADMA ratio. Despite the close but opposite associations of hArg and ADMA with disease in adults, children and adolescents, the underlying biochemical processes are largely unknown, presumably not restricted to NO, and warrant deeper investigation. As the common substrate for hArg and ADMA, Arg may play a key role in the biosynthesis and homeostasis of hArg and ADMA, two putative antagonists. In animal models of stroke and obesity, hArg has beneficial effects. The potential utility of hArg as a therapeutic drug or nutritional supplement in humans and animals remains to be elaborated.


Assuntos
Homoarginina , Obesidade , Acidente Vascular Cerebral , Adolescente , Adulto , Animais , Transporte Biológico Ativo , Modelos Animais de Doenças , Feminino , Homoarginina/análogos & derivados , Homoarginina/sangue , Homoarginina/urina , Humanos , Masculino , Obesidade/sangue , Obesidade/urina , Gravidez , Acidente Vascular Cerebral/sangue , Acidente Vascular Cerebral/urina
17.
Br J Nutr ; 113(4): 683-90, 2015 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-25634494

RESUMO

Phyto-oestrogens are a family of plant-derived xeno-oestrogens that have been shown to prevent cancer in some studies. Whether phyto-oestrogen intake affects obesity status in a population is still unclear. In the present cross-sectional study, we examined the association of urinary phyto-oestrogen metabolites with obesity and metabolic parameters in children and adults. Data from 1294 children (age 6-19 years) and from 3661 adults (age ≥ 20 years) who participated in the US National Health and Nutrition Examination Survey 2001-10 were analysed. Multivariate logistic regression was applied to investigate the associations of BMI, waist circumference, serum metabolites (total cholesterol, HDL-cholesterol, LDL-cholesterol, TAG, fasting glucose and fasting insulin) and the metabolic syndrome with urinary phyto-oestrogen levels. When stratified by age and sex, we found a stronger association (OR 0·30, 95 % CI 0·17, 0·54; P< 0·001) between urinary enterolactone levels and obesity in adult males (age 20-60 years) than in children (age 12-19 years) or the elderly (age >60 years) in the same survey. However, no associations with urinary daidzein, O-desmethylangolensin, equol, enterodiol or genistein were found in the overall population. We also found that the elevation of enterolactone levels was inversely associated with TAG levels, fasting glucose levels, fasting insulin levels and the metabolic syndrome in males aged 20-60 years, but positively associated with HDL-cholesterol levels. The present results provide epidemiological evidence that urinary enterolactone is inversely associated with obesity in adult males.


Assuntos
4-Butirolactona/análogos & derivados , Regulação para Baixo , Lignanas/urina , Síndrome Metabólica/urina , Obesidade/urina , Fitoestrógenos/urina , 4-Butirolactona/urina , Adolescente , Adulto , Fatores Etários , Idoso , Índice de Massa Corporal , Criança , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Inquéritos Nutricionais , Caracteres Sexuais , Estados Unidos , Circunferência da Cintura , Adulto Jovem
18.
J Trace Elem Med Biol ; 29: 116-22, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25194955

RESUMO

OBJECTIVE: To determine serum and urinary selenium (Se) levels in children with and without obesity, and to assess if Se influences the risk of obesity. SUBJECTS AND METHODS: High-resolution-continuum source-atomic absorption spectrometry (HR-CS-AAS) was used to determine the content of Se in 80 children (age 6-17; 40 boys, 40 girls). Correlations between variables were tested with the use of Spearman's correlation coefficient. U Mann-Whitney test was applied to assess the difference of Se contents in samples. Measured metabolic risk factors (blood pressure, glucose level, triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol), age, gender, and BMI were correlated. Logistic regression models were fitted to identify predictors of obesity interacting with selenium content in serum and urine, separately. RESULTS: Obese children, regardless of gender, had lower Se content. Se level in serum (p=0.001, OR 0.74, 95%CI 0.62-0.88) and total cholesterol (p=0.001, OR 1.19, 95%CI 1.08-1.31) were the independent factors significantly influencing the risk of obesity in children. Two separate models were observed for Se in urine: (i) Se level (p<0. 0001, OR 0.70, 95%CI 0.58-0.84) and glucose level (p<0.0001, OR 1.22, 95%CI 1.10-1.35), and (ii) Se level (p=0.002, OR 0.60 95%CI 0.43-0.83) and total cholesterol level (p=0.003, OR 1.16, 95%CI 1.05-1.28). CONCLUSION: The current study suggests a possible role of Se in obesity. Further research needs to be performed to check if obese children are an at-risk group for Se deficiency.


Assuntos
Obesidade/sangue , Obesidade/urina , Selênio/sangue , Selênio/urina , Adolescente , Estudos de Casos e Controles , Criança , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Análise Multivariada
19.
J Nutr ; 144(9): 1445-53, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24966407

RESUMO

The study objective was to evaluate independent and interactive associations of dietary fiber intake and high urinary enterolignans with cardiometabolic risk factors. The analysis included 2260 adults (≥20 y of age) from the 2003-2010 NHANES. Logistic regression models were used to evaluate obesity and clinically defined cardiometabolic risk factors in relation to dietary fiber intake and urinary enterolignan concentrations. Three sets of models were created: 1) independent associations, 2) mutually adjusted associations, and 3) interactions. Models were adjusted for age, gender, race/ethnicity, education, smoking status, and energy intake. High concentrations were considered to be above the 90th percentile of urinary enterolignan concentrations. Increasing dietary fiber intake was associated with high blood pressure (P = 0.02) and low serum HDL cholesterol (P-trend = 0.03). High urinary enterodiol concentration was not associated with obesity or cardiometabolic risk factors. High urinary enterolactone concentration was inversely associated with obesity (OR: 0.44; 95% CI: 0.29, 0.66), abdominal obesity (OR: 0.58; 95% CI: 0.39, 0.87), high serum C-reactive protein (CRP; OR: 0.52; 95% CI: 0.37, 0.74), high serum triglycerides (OR: 0.39; 95% CI: 0.23, 0.61), low serum HDL cholesterol (OR: 0.37; 95% CI: 0.23, 0.61), and metabolic syndrome (OR: 0.47; 95% CI: 0.30, 0.74). In mutually adjusted models, enterolactone associations observed in independent models remained similar, but associations for dietary fiber intake were attenuated, with the exception of blood pressure. In interaction models, there were 2 significant interactions: between high urinary enterodiol concentration and dietary fiber intake for high serum CRP (P = 0.04) and high plasma glucose (P = 0.04). Overall, being in the highest 10% of urinary enterolactone concentration was associated with cardiometabolic risk factors, independent of dietary fiber intake and enterodiol concentration. Future studies are warranted to evaluate physiologic actions of enterolactone or aspects of the gut microbial profile responsible for lignan metabolism to enterolactone.


Assuntos
4-Butirolactona/análogos & derivados , Doenças Cardiovasculares/urina , Fibras na Dieta/farmacologia , Lignanas/urina , Síndrome Metabólica/urina , Obesidade/urina , Fitoestrógenos/urina , 4-Butirolactona/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Glicemia/metabolismo , Pressão Sanguínea , Proteína C-Reativa/metabolismo , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/prevenção & controle , HDL-Colesterol/sangue , Feminino , Humanos , Modelos Logísticos , Masculino , Síndrome Metabólica/sangue , Síndrome Metabólica/complicações , Síndrome Metabólica/prevenção & controle , Pessoa de Meia-Idade , Inquéritos Nutricionais , Obesidade/sangue , Obesidade/complicações , Obesidade/prevenção & controle , Razão de Chances , Fatores de Risco , Triglicerídeos/sangue
20.
J Endourol ; 28(2): 248-51, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24032438

RESUMO

INTRODUCTION: Obese patients have an increased risk of kidney stones, and several studies have identified specific urinary derangements on 24-hour collections. The objective of this study was to assess obese and super-obese stone formers, and their compliance with dietary modifications over time, based on 24-hour urine outcomes. PATIENTS AND METHODS: A retrospective review was performed searching for all stone formers who completed a 24-hour urine collection before and after dietary counseling for stone prevention. Patients were excluded if placed on medical therapy in addition to dietary therapy. Patients were divided in three main groups according to their body mass index (BMI): 30, 30-40, and >40 kg/m(2). Demographic data and 24-hour urine stone risk parameters (volume, sodium, uric acid, citrate, and oxalate) were assessed. Initial 24-hour urine results were compared to follow-up results after dietary counseling. Then, the outcomes from each group were compared to each other. RESULTS: Two hundred and fourteen stone formers (67% male) were identified with a mean age of 49.5±15.0 years. One hundred twenty-eight (59.8%) patients had BMI <30 kg/m(2), 61 (28.5%) between 30-40 kg/m(2), and 25 (11.7%) >40 kg/m(2). Among patients with BMI <30 kg/m(2), there were significant improvements in all urinary parameters (p<0.001) as well as in the group with BMI between 30 to 40 kg/m(2) (p=0.02 for oxalate, p<0.001 for other parameters). Among super-obese patients, there were significant improvements in the urinary volume (p=0.03), sodium (p<0.001), uric acid (p=0.001), and oxalate (p<0.001). There were no significant differences in the improvements observed in the urinary volume (p=0.69), sodium (p=0.08), uric acid (p=0.17), and citrate levels (p=0.97) between the groups. CONCLUSION: Dietary recommendations can be an equally effective strategy in decreasing the risk or stone recurrence in obese and super-obese kidney stone formers as it is in those who are not obese.


Assuntos
Suplementos Nutricionais , Cálculos Renais/dietoterapia , Obesidade/complicações , Adulto , Índice de Massa Corporal , Ácido Cítrico/urina , Feminino , Seguimentos , Humanos , Cálculos Renais/etiologia , Cálculos Renais/urina , Masculino , Pessoa de Meia-Idade , Obesidade/urina , Oxalatos/urina , Estudos Retrospectivos , Sódio/urina , Ácido Úrico/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA